Bela F. Asztalos
Lipid Metabolism Laboratory
Tufts University
711 Washington Street
Boston
USA
Name/email consistency: high
- High-density lipoprotein particles, coronary heart disease, and niacin. Asztalos, B.F. J. Clin. Lipidol (2010)
- Effects of weight loss, induced by gastric bypass surgery, on HDL remodeling in obese women. Asztalos, B.F., Swarbrick, M.M., Schaefer, E.J., Dallal, G.E., Horvath, K.V., Ai, M., Stanhope, K.L., Austrheim-Smith, I., Wolfe, B.M., Ali, M., Havel, P.J. J. Lipid Res. (2010)
- Relation of gemfibrozil treatment and high-density lipoprotein subpopulation profile with cardiovascular events in the Veterans Affairs High-Density Lipoprotein Intervention Trial. Asztalos, B.F., Collins, D., Horvath, K.V., Bloomfield, H.E., Robins, S.J., Schaefer, E.J. Metab. Clin. Exp. (2008)
- Comparison of the effects of high doses of rosuvastatin versus atorvastatin on the subpopulations of high-density lipoproteins. Asztalos, B.F., Le Maulf, F., Dallal, G.E., Stein, E., Jones, P.H., Horvath, K.V., McTaggart, F., Schaefer, E.J. Am. J. Cardiol. (2007)
- Role of LCAT in HDL remodeling: investigation of LCAT deficiency states. Asztalos, B.F., Schaefer, E.J., Horvath, K.V., Yamashita, S., Miller, M., Franceschini, G., Calabresi, L. J. Lipid Res. (2007)
- Protease inhibitor-based HAART, HDL, and CHD-risk in HIV-infected patients. Asztalos, B.F., Schaefer, E.J., Horvath, K.V., Cox, C.E., Skinner, S., Gerrior, J., Gorbach, S.L., Wanke, C. Atherosclerosis (2006)
- LpA-I, LpA-I:A-II HDL and CHD-risk: The Framingham Offspring Study and the Veterans Affairs HDL Intervention Trial. Asztalos, B.F., Demissie, S., Cupples, L.A., Collins, D., Cox, C.E., Horvath, K.V., Bloomfield, H.E., Robins, S.J., Schaefer, E.J. Atherosclerosis (2006)
- Differential effects of HDL subpopulations on cellular ABCA1- and SR-BI-mediated cholesterol efflux. Asztalos, B.F., de la Llera-Moya, M., Dallal, G.E., Horvath, K.V., Schaefer, E.J., Rothblat, G.H. J. Lipid Res. (2005)
- Value of high-density lipoprotein (HDL) subpopulations in predicting recurrent cardiovascular events in the Veterans Affairs HDL Intervention Trial. Asztalos, B.F., Collins, D., Cupples, L.A., Demissie, S., Horvath, K.V., Bloomfield, H.E., Robins, S.J., Schaefer, E.J. Arterioscler. Thromb. Vasc. Biol. (2005)
- Apolipoprotein composition of HDL in cholesteryl ester transfer protein deficiency. Asztalos, B.F., Horvath, K.V., Kajinami, K., Nartsupha, C., Cox, C.E., Batista, M., Schaefer, E.J., Inazu, A., Mabuchi, H. J. Lipid Res. (2004)
- High-density lipoprotein metabolism and progression of atherosclerosis: new insights from the HDL Atherosclerosis Treatment Study. Asztalos, B.F. Curr. Opin. Cardiol. (2004)
- High-density lipoprotein subpopulation profile and coronary heart disease prevalence in male participants of the Framingham Offspring Study. Asztalos, B.F., Cupples, L.A., Demissie, S., Horvath, K.V., Cox, C.E., Batista, M.C., Schaefer, E.J. Arterioscler. Thromb. Vasc. Biol. (2004)
- Change in alpha1 HDL concentration predicts progression in coronary artery stenosis. Asztalos, B.F., Batista, M., Horvath, K.V., Cox, C.E., Dallal, G.E., Morse, J.S., Brown, G.B., Schaefer, E.J. Arterioscler. Thromb. Vasc. Biol. (2003)
- HDL in atherosclerosis: actor or bystander?. Asztalos, B.F., Schaefer, E.J. Atheroscler. Suppl (2003)